Get the Stockscreener App
2.99
2.40%
0.07
Absci Corp stock is traded at $2.99, with a volume of 2.42M.
It is up +2.40% in the last 24 hours and up +11.57% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.92
Open:
$2.88
24h Volume:
2.42M
Relative Volume:
1.65
Market Cap:
$343.42M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-2.4508
EPS:
-1.22
Net Cash Flow:
$-70.76M
1W Performance:
-19.08%
1M Performance:
+11.57%
6M Performance:
+2.40%
1Y Performance:
-2.29%
1-Day Range:
$2.86
$3.085
1-Week Range:
$2.7925
$4.11
52-Week Range:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.99 | 343.42M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Absci shares reiterated at Buy at H.C. Wainwright following R&D day - Investing.com
Absci shares reiterated at Buy at H.C. Wainwright following R&D day By Investing.com - Investing.com UK
Wilmington Savings Fund Society FSB Acquires New Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Charles Schwab Investment Management Inc. Grows Position in Absci Co. (NASDAQ:ABSI) - Defense World
Verition Fund Management LLC Takes Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci Co. (NASDAQ:ABSI) Receives $8.67 Average Target Price from Analysts - MarketBeat
Absci Co. (NASDAQ:ABSI) Receives Consensus Rating of “Buy” from Analysts - Defense World
Absci (NASDAQ:ABSI) Given Buy Rating at HC Wainwright - MarketBeat
Absci highlights progress, updates across proprietary pipeline - Yahoo Finance
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day - GlobeNewswire
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga
United Natural Foods Posts Upbeat Results, Joins Alphabet, Ollie's Bargain, MoneyLion And Other Big Stocks Moving Higher On Tuesday - Benzinga
Wall Street Analysts Were Busy This Morning - MSN
Absci Corporation (NASDAQ:ABSI) is favoured by institutional owners who hold 56% of the company - Yahoo Finance
Absci initiated with a Buy at JonesResearch - MSN
Cathie Wood's ARK buys Absci stock, sells Butterfly and Senti By Investing.com - Investing.com Nigeria
Cathie Wood's ARK buys Absci stock, sells Butterfly and Senti - Investing.com India
Absci a new buy at Jones on AI platform to design antibodies - Seeking Alpha
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
Jones Trading bullish on Absci stock, highlights unique AI platform & pharma deals - Investing.com
TSX Financials Capped Index (TTFS) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
Victory Capital Management Inc. Has $575,000 Stock Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Portland InnoA founder's return | Absci heads to Europe - The Business Journals
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care - Benzinga
Absci Corporation: Struggling To Live Up To Its AI Promise (NASDAQ:ABSI) - Seeking Alpha
HC Wainwright Has Negative Outlook of Absci FY2024 Earnings - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q3 2024 Earnings Call Transcript - Insider Monkey
FMR LLC Acquires Significant Stake in Absci Corp - GuruFocus.com
Absci Corporation Advances AI-Driven Drug Development - TipRanks
Absci earnings missed by $0.05, revenue fell short of estimates - Investing.com South Africa
Absci Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results - Yahoo Finance
Earnings Scheduled For November 12, 2024 - Benzinga
Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For - GuruFocus.com
Absci (ABSI) Set to Announce Earnings on Tuesday - Defense World
4 Biotech Stocks With AI, Machine Learning Prowess - Head Topics
Absci to Host R&D Day on December 12, 2024 - Yahoo Finance
Absci Sets AI Drug Innovation Showcase at 2024 R&D Day Event - StockTitan
I: Exploring 🧭 TechBio - substack.com
Absci (ABSI) Scheduled to Post Earnings on Tuesday - MarketBeat
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
You might want to take a look at Absci Corp (ABSI) now - SETE News
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Absci Corp Stock (ABSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
| Redmile Group, LLC | Director |
Mar 01 '24 |
Buy |
4.50 |
222,222 |
999,999 |
8,253,316 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):